Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific ABCB1 ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1 ENSG00000085563 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7 87503633-87713323 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001716, HPA002199 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm, Focal Adhesions Tissue enhanced 0 adrenal gland: 89.8;small intestine: 56.6 kidney: 24.5 ABCG2 ABCP, BCRP, CD338, EST157481, MXR ENSG00000118777 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) 4 88090264-88231322 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037299, HPA054719 Supportive Supportive Plasma membrane, Nucleus Tissue enhanced 0 small intestine: 80.8 duodenum: 41.0 ACE ACE1, CD143, DCP1 ENSG00000159640 Angiotensin I converting enzyme 17 63477061-63498380 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002426, CAB002921, HPA029298 Supportive Group enriched 6 duodenum: 127.7;lung: 50.7;small intestine: 194.5;testis: 45.7 thyroid gland: 17.0 ACKR1 CCBP1, CD234, DARC, Dfy, FY, GPD ENSG00000213088 Atypical chemokine receptor 1 (Duffy blood group) 1 159203307-159206500 Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA016421, HPA017672 Supportive Mixed adipose tissue: 71.9 ADAM10 CD156c, HsT18717, kuz, MADM ENSG00000137845 ADAM metallopeptidase domain 10 15 58588807-58749978 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001709, HPA050670 Uncertain Supportive Plasma membrane, Vesicles Expressed in all urinary bladder: 37.1 ADAM17 CD156B, cSVP, TACE ENSG00000151694 ADAM metallopeptidase domain 17 2 9488486-9555792 CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010738, CAB025906, HPA051575 Supportive Supportive Cytoplasm Expressed in all placenta: 17.3 ADAM8 CD156, CD156a, MS2 ENSG00000151651 ADAM metallopeptidase domain 8 10 133262403-133276868 CD markers, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064637 Uncertain Tissue enhanced 0 bone marrow: 30.4 spleen: 20.9 ALCAM CD166, MEMD ENSG00000170017 Activated leukocyte cell adhesion molecule 3 105366909-105576900 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002148, HPA010926 Supportive Uncertain Cytoplasm Mixed lung: 67.4 ALK CD246 ENSG00000171094 Anaplastic lymphoma receptor tyrosine kinase 2 29192774-29921566 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010694 Uncertain Tissue enhanced 0 cerebral cortex: 1.6;testis: 0.9 adrenal gland: 0.5 ANPEP CD13, gp150, LAP1, p150, PEPN ENSG00000166825 Alanyl (membrane) aminopeptidase 15 89784889-89815401 CD markers, Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002417, HPA004625 Supportive Group enriched 7 duodenum: 1728.9;small intestine: 1446.4 kidney: 213.5 ART1 ART2, CD296 ENSG00000129744 ADP-ribosyltransferase 1 11 3645128-3664416 CD markers, Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051148 Uncertain Tissue enriched 25 skeletal muscle: 10.3 esophagus: 0.4 ART4 CD297, DO, DOK1 ENSG00000111339 ADP-ribosyltransferase 4 (Dombrock blood group) 12 14825569-14843495 Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040879 Uncertain Tissue enhanced 0 liver: 11.4;spleen: 11.2 gallbladder: 8.2 ATP1B3 CD298, FLJ29027 ENSG00000069849 ATPase, Na+/K+ transporting, beta 3 polypeptide 3 141876124-141926514 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020697, HPA048963 Uncertain Supportive Plasma membrane Expressed in all skin: 178.2 BCAM CD239, LU ENSG00000187244 Basal cell adhesion molecule (Lutheran blood group) 19 44809059-44821420 Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005654 Uncertain Uncertain Nucleoli Expressed in all kidney: 142.7 BMPR1A ACVRLK3, ALK3, CD292 ENSG00000107779 Bone morphogenetic protein receptor, type IA 10 86756650-86932838 Cancer-related genes, CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB019398 Uncertain Uncertain Cytoplasm Mixed thyroid gland: 13.9 BMPR1B ALK6, CDw293 ENSG00000138696 Bone morphogenetic protein receptor, type IB 4 94757968-95158448 CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB009634 Uncertain Tissue enhanced 0 fallopian tube: 14.5;prostate: 23.5 cerebral cortex: 9.6 BSG CD147, EMMPRIN, OK ENSG00000172270 Basigin (Ok blood group) 19 571309-583493 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002427, HPA036048 Supportive Expressed in all heart muscle: 509.7 BST1 CD157 ENSG00000109743 Bone marrow stromal cell antigen 1 4 15702950-15738313 CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050121 Uncertain Expressed in all bone marrow: 80.2 BST2 CD317, tetherin ENSG00000130303 Bone marrow stromal cell antigen 2 19 17402939-17405648 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017060 Uncertain Supportive Plasma membrane, Cytoplasm, Golgi apparatus Expressed in all ovary: 387.4 BTLA BTLA1, CD272 ENSG00000186265 B and T lymphocyte associated 3 112463968-112499561 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047211, HPA062029 Supportive Group enriched 6 appendix: 8.9;lymph node: 21.5;spleen: 8.8;tonsil: 23.3 stomach: 2.5 BTN3A1 BT3.1, BTF5, BTN3.1, CD277 ENSG00000026950 Butyrophilin, subfamily 3, member A1 6 26402237-26415216 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012565 Uncertain Uncertain Vesicles Expressed in all spleen: 51.5 C5AR1 C5A, C5AR, C5R1, CD88 ENSG00000197405 Complement component 5a receptor 1 19 47290023-47322066 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002720, HPA014520 Uncertain Supportive Plasma membrane, Cytoplasm Tissue enhanced 0 appendix: 73.8 bone marrow: 65.1 CCR2 CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R ENSG00000121807 Chemokine (C-C motif) receptor 2 3 46353734-46360928 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB003793 Uncertain Tissue enhanced 0 appendix: 31.7 lymph node: 12.0 CCR3 CC-CKR-3, CD193, CKR3, CMKBR3 ENSG00000183625 Chemokine (C-C motif) receptor 3 3 46163604-46266706 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB003795 Uncertain Mixed urinary bladder: 2.1 CCR4 CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5 ENSG00000183813 Chemokine (C-C motif) receptor 4 3 32951574-32956349 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031613 Uncertain Tissue enhanced 0 appendix: 7.7;urinary bladder: 7.7 tonsil: 6.8 CCR6 BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22 ENSG00000112486 Chemokine (C-C motif) receptor 6 6 167122769-167139696 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006820, HPA014488 Supportive Tissue enhanced 0 lymph node: 10.1;tonsil: 19.7 spleen: 7.0 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003796 Supportive Group enriched 5 appendix: 57.6;lymph node: 68.9;spleen: 23.6;tonsil: 67.3 urinary bladder: 9.9 CCR9 CDw199, GPR-9-6, GPR28 ENSG00000173585 Chemokine (C-C motif) receptor 9 3 45886504-45903177 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006839 Uncertain Group enriched 6 appendix: 1.0;duodenum: 2.9;small intestine: 4.1;spleen: 0.9 tonsil: 0.4 CD101 IGSF2, V7 ENSG00000134256 CD101 molecule 1 117001750-117036476 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057763 Uncertain Mixed small intestine: 4.4 CD109 CPAMD7, DKFZp762L1111, FLJ38569 ENSG00000156535 CD109 molecule 6 73695785-73828316 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009292, HPA015113 Uncertain Mixed skin: 13.8 CD14 ENSG00000170458 CD14 molecule 5 140631728-140633701 Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001887, HPA002127, CAB033631, CAB072865, CAB072866 Supportive Expressed in all placenta: 150.7 CD151 PETA-3, RAPH, SFA-1, TSPAN24 ENSG00000177697 CD151 molecule (Raph blood group) 11 832843-839831 Blood group antigen proteins, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002428, HPA011906 Supportive Expressed in all adipose tissue: 211.0 CD163 M130, MM130 ENSG00000177575 CD163 molecule 12 7470813-7503893 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002432, HPA046404, HPA051974 Supportive Expressed in all appendix: 144.5 CD163L1 CD163B, M160 ENSG00000177675 CD163 molecule-like 1 12 7346685-7479897 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015663 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm, Centrosome Tissue enhanced 0 spleen: 23.0 rectum: 16.9 CD164 MGC-24, MUC-24 ENSG00000135535 CD164 molecule, sialomucin 6 109366514-109382559 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA010636 Uncertain Expressed in all thyroid gland: 334.8 CD180 LY64, Ly78, RP105 ENSG00000134061 CD180 molecule 5 67182275-67196799 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003740 Supportive Tissue enhanced 0 lymph node: 36.5;tonsil: 36.0 spleen: 18.6 CD19 ENSG00000177455 CD19 molecule 16 28931939-28939346 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016110 Supportive Group enriched 9 appendix: 24.3;lymph node: 61.4;spleen: 33.9;tonsil: 64.3 urinary bladder: 4.9 CD1A CD1 ENSG00000158477 CD1a molecule 1 158254137-158258269 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000009, HPA010734 Supportive Tissue enhanced 0 esophagus: 7.4;skin: 15.6 tonsil: 2.3 CD1B CD1 ENSG00000158485 CD1b molecule 1 158327951-158331531 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021824 Uncertain Mixed rectum: 1.9 CD1D ENSG00000158473 CD1d molecule 1 158179947-158184896 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB016107 Uncertain Mixed appendix: 11.1 CD1E ENSG00000158488 CD1e molecule 1 158353696-158357553 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057769 Uncertain Mixed skin: 10.5 CD2 SRBC ENSG00000116824 CD2 molecule 1 116754385-116769228 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002430, HPA003883 Supportive Supportive Nucleus but not nucleoli, Nucleoli Tissue enhanced 0 lymph node: 94.5 tonsil: 60.6 CD200 MOX1, MOX2, MRC, OX-2 ENSG00000091972 CD200 molecule 3 112332347-112362812 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031149 Uncertain Mixed cerebral cortex: 40.3 CD207 CLEC4K, Langerin ENSG00000116031 CD207 molecule, langerin 2 70830214-70835822 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002222, HPA011216 Supportive Uncertain Cytoplasm Group enriched 9 esophagus: 14.2;skin: 58.2 tonsil: 3.8 CD209 CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1 ENSG00000090659 CD209 molecule 19 7739994-7747564 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032436, CAB033831 Supportive Mixed adipose tissue: 26.6 CD22 SIGLEC-2, SIGLEC2 ENSG00000012124 CD22 molecule 19 35319261-35347355 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002418, HPA024353 Supportive Uncertain Nucleus, Cytoplasm Tissue enhanced 0 lymph node: 149.8;tonsil: 165.1 ovary: 97.9 CD226 DNAM-1, DNAM1, PTA1, TLiSA1 ENSG00000150637 CD226 molecule 18 69831158-69961803 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015715 Supportive Tissue enhanced 0 spleen: 17.7 lymph node: 9.4 CD244 2B4, NAIL, NKR2B4, Nmrk, SLAMF4 ENSG00000122223 CD244 molecule, natural killer cell receptor 2B4 1 160830160-160862855 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010628 Uncertain Tissue enhanced 0 spleen: 12.1 bone marrow: 5.4 CD247 CD3H, CD3Q, CD3Z ENSG00000198821 CD247 molecule 1 167430640-167518610 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004651, HPA008750 Supportive Tissue enhanced 0 lymph node: 51.5 tonsil: 32.6 CD248 CD164L1, TEM1 ENSG00000174807 CD248 molecule, endosialin 11 66314487-66317044 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051856 Uncertain Uncertain Nucleus but not nucleoli, Plasma membrane Tissue enhanced 0 adipose tissue: 85.9 placenta: 69.5 CD27 S152, TNFRSF7, Tp55 ENSG00000139193 CD27 molecule 12 6444867-6451718 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002420, HPA038936 Supportive Tissue enhanced 0 lymph node: 103.8;tonsil: 77.4 spleen: 47.0 CD274 B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1 ENSG00000120217 CD274 molecule 9 5450503-5470566 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB030018 Uncertain Mixed appendix: 9.2 CD276 B7-H3, B7H3, B7RP-2 ENSG00000103855 CD276 molecule 15 73683966-73714518 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009285, HPA017139, CAB017826 Supportive Uncertain Vesicles Mixed placenta: 22.2 CD300A CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60 ENSG00000167851 CD300a molecule 17 74466416-74484796 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011645 Uncertain Expressed in all spleen: 49.5 CD300C CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR ENSG00000167850 CD300c molecule 17 74541108-74546143 CD markers, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014523 Uncertain Mixed lung: 6.8 CD300E CD300LE, CLM2, IREM2 ENSG00000186407 CD300e molecule 17 74609887-74623738 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015570 Uncertain Tissue enhanced 0 appendix: 31.2;bone marrow: 23.5 adipose tissue: 10.2 CD300LD CD300D, CMRF35A4 ENSG00000204345 CD300 molecule-like family member d 17 74579365-74592283 CD markers, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level HPA027756 Uncertain Not detected appendix: 0.4 CD300LF CD300f, CLM1, IGSF13, IREM1, NKIR ENSG00000186074 CD300 molecule-like family member f 17 74694311-74712978 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013712 Supportive Tissue enhanced 0 spleen: 16.4 bone marrow: 12.6 CD300LG CLM9, Trem4 ENSG00000161649 CD300 molecule-like family member g 17 43847148-43863629 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004131 Uncertain Tissue enhanced 0 adipose tissue: 93.1;placenta: 37.6 testis: 20.3 CD320 8D6, 8D6A ENSG00000167775 CD320 molecule 19 8302127-8308356 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014500, HPA073489 Uncertain Uncertain Cytoplasm Expressed in all spleen: 39.2 CD33 FLJ00391, p67, SIGLEC-3, SIGLEC3 ENSG00000105383 CD33 molecule 19 51225064-51243860 CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011442, HPA035832, HPA064807 Uncertain Supportive Nucleus, Plasma membrane Mixed spleen: 20.1 CD34 ENSG00000174059 CD34 molecule 1 207880972-207911402 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000018, HPA036722, HPA036723 Supportive Expressed in all placenta: 159.1 CD36 FAT, GP3B, GP4, GPIV, SCARB3 ENSG00000135218 CD36 molecule (thrombospondin receptor) 7 80369575-80679277 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002018, CAB025866 Supportive Expressed in all adipose tissue: 1060.0 CD37 TSPAN26 ENSG00000104894 CD37 molecule 19 49335171-49343335 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002492, HPA032120, HPA032121 Supportive Tissue enhanced 0 lymph node: 164.5;spleen: 151.7 appendix: 77.2 CD38 ENSG00000004468 CD38 molecule 4 15778275-15853230 Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002493, HPA022132, CAB025255, HPA052381 Supportive Uncertain Plasma membrane, Vesicles Mixed lymph node: 22.6 CD3D T3D ENSG00000167286 CD3d molecule, delta (CD3-TCR complex) 11 118338954-118342744 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013055 Supportive Tissue enhanced 0 lymph node: 130.9;tonsil: 95.8 appendix: 53.3 CD3E ENSG00000198851 CD3e molecule, epsilon (CD3-TCR complex) 11 118304545-118316175 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000010, HPA040957, HPA043955, CAB072863, CAB072864 Supportive Tissue enhanced 0 lymph node: 162.1;tonsil: 109.6 appendix: 65.7 CD3G ENSG00000160654 CD3g molecule, gamma (CD3-TCR complex) 11 118344344-118355161 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017520, HPA038494 Supportive Tissue enhanced 0 lymph node: 28.9;tonsil: 21.5 appendix: 11.7 CD4 ENSG00000010610 CD4 molecule 12 6786858-6820808 CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000011, HPA004252, HPA004472, CAB068180 Supportive Supportive Plasma membrane Expressed in all spleen: 132.3 CD40 Bp50, p50, TNFRSF5 ENSG00000101017 CD40 molecule, TNF receptor superfamily member 5 20 46118272-46129863 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002495, HPA031567, HPA031568, CAB072868 Supportive Expressed in all lymph node: 44.1 CD40LG CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP ENSG00000102245 CD40 ligand X 136648193-136660390 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045827 Supportive Uncertain Tissue enhanced 0 lymph node: 12.6;tonsil: 12.2 appendix: 6.6 CD44 CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1 ENSG00000026508 CD44 molecule (Indian blood group) 11 35138870-35232402 Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000112, CAB000316, HPA005785 Supportive Supportive Plasma membrane, Golgi apparatus Expressed in all skin: 307.2 CD46 MCP, MGC26544, MIC10, TLX, TRA2.10 ENSG00000117335 CD46 molecule, complement regulatory protein 1 207752057-207795513 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010401, HPA016903 Supportive Uncertain Plasma membrane Expressed in all adrenal gland: 217.3 CD47 IAP, MER6, OA3 ENSG00000196776 CD47 molecule 3 108043298-108091025 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016055, HPA044659 Supportive Supportive Nucleus but not nucleoli, Golgi apparatus, Vesicles Expressed in all lung: 102.5 CD48 BCM1, BLAST, hCD48, mCD48, SLAMF2 ENSG00000117091 CD48 molecule 1 160678746-160711851 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002497 Supportive Tissue enhanced 0 lymph node: 229.3;tonsil: 205.6 spleen: 130.9 CD5 LEU1, T1 ENSG00000110448 CD5 molecule 11 61102395-61127852 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015392, CAB020308, HPA043416, HPA060839 Supportive Uncertain Tissue enhanced 0 lymph node: 30.7 appendix: 19.7 CD53 MOX44, TSPAN25 ENSG00000143119 CD53 molecule 1 110873154-110899928 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047216 Uncertain Expressed in all tonsil: 366.5 CD55 CR, CROM, DAF, TC ENSG00000196352 CD55 molecule, decay accelerating factor for complement (Cromer blood group) 1 207321508-207360966 Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002190, CAB010454, HPA024386 Supportive Expressed in all lung: 205.3 CD59 16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20 ENSG00000085063 CD59 molecule, complement regulatory protein 11 33698261-33736445 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001448, HPA026494 Supportive Uncertain Golgi apparatus, Vesicles Expressed in all gallbladder: 400.8 CD6 Tp120 ENSG00000013725 CD6 molecule 11 60971680-61020377 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002489, CAB016252 Supportive Uncertain Tissue enhanced 0 lymph node: 32.3;tonsil: 22.0 appendix: 18.3 CD63 ME491, MLA1, TSPAN30 ENSG00000135404 CD63 molecule 12 55725323-55729707 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010088, CAB026356 Supportive Supportive Vesicles Expressed in all rectum: 580.3 CD68 DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1 ENSG00000129226 CD68 molecule 17 7579467-7582113 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000051, CAB000066, HPA048982, CAB072861, CAB072862 Supportive Supportive Golgi apparatus, Vesicles Expressed in all spleen: 320.8 CD69 CLEC2C ENSG00000110848 CD69 molecule 12 9752486-9760901 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002503, HPA050525 Supportive Tissue enhanced 0 bone marrow: 84.7;lymph node: 73.9 tonsil: 48.8 CD7 GP40, LEU-9, Tp40, TP41 ENSG00000173762 CD7 molecule 17 82314868-82317602 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002594, HPA039079 Supportive Tissue enhanced 0 lymph node: 25.7;spleen: 30.5 appendix: 21.4 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002505, HPA044658 Supportive Group enriched 7 appendix: 16.9;lymph node: 52.3;spleen: 42.6;tonsil: 35.7 urinary bladder: 5.5 CD74 DHLAG ENSG00000019582 CD74 molecule, major histocompatibility complex, class II invariant chain 5 150401637-150412929 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002506, HPA010592 Supportive Uncertain Golgi apparatus Expressed in all spleen: 4341.1 CD79A IGA, MB-1 ENSG00000105369 CD79a molecule, immunoglobulin-associated alpha 19 41877120-41881372 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000019, HPA017748 Supportive Tissue enhanced 0 lymph node: 351.7;spleen: 234.8;tonsil: 379.7 appendix: 168.1 CD79B B29, IGB ENSG00000007312 CD79b molecule, immunoglobulin-associated beta 17 63928740-63932354 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009178, CAB009751 Uncertain Supportive Nucleus but not nucleoli, Plasma membrane, Cytoplasm Tissue enhanced 0 lymph node: 222.7;spleen: 108.8;tonsil: 167.1 appendix: 63.1 CD80 B7-1, B7.1, CD28LG, CD28LG1 ENSG00000121594 CD80 molecule 3 119524293-119559602 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025368, HPA050092 Supportive Tissue enhanced 0 appendix: 4.1;lymph node: 4.5;tonsil: 5.0 spleen: 2.1 CD81 TAPA-1, TAPA1, TSPAN28 ENSG00000110651 CD81 molecule 11 2376177-2397419 CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002507, HPA007234 Supportive Supportive Plasma membrane, Cytoplasm Expressed in all fallopian tube: 896.5 CD82 IA4, KAI1, R2, ST6, TSPAN27 ENSG00000085117 CD82 molecule 11 44564427-44620363 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002508, HPA028900, HPA061418 Supportive Uncertain Vesicles Expressed in all esophagus: 117.5 CD83 BL11, HB15 ENSG00000112149 CD83 molecule 6 14117256-14136918 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002509, HPA041454 Supportive Uncertain Vesicles Tissue enhanced 0 bone marrow: 97.9 tonsil: 57.9 CD84 hCD84, mCD84, SLAMF5 ENSG00000066294 CD84 molecule 1 160541095-160579516 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070502 Supportive Tissue enhanced 0 lymph node: 21.2 appendix: 17.0 CD86 B7-2, B7.2, CD28LG2 ENSG00000114013 CD86 molecule 3 122055366-122121139 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004319 Uncertain Mixed appendix: 31.6 CD8A CD8 ENSG00000153563 CD8a molecule 2 86784610-86808396 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000012, HPA037756, CAB075722 Supportive Tissue enhanced 0 spleen: 89.8 lymph node: 35.8 CD8B CD8B1 ENSG00000172116 CD8b molecule 2 86815339-86861924 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004353 Supportive Tissue enhanced 0 lymph node: 26.1 tonsil: 14.2 CD9 BA2, MIC3, MRP-1, P24, TSPAN29 ENSG00000010278 CD9 molecule 12 6199715-6238271 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002490 Supportive Supportive Plasma membrane Expressed in all esophagus: 691.4 CD93 C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4 ENSG00000125810 CD93 molecule 20 23079349-23086340 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009300, HPA012368 Supportive Expressed in all placenta: 90.8 CD96 TACTILE ENSG00000153283 CD96 molecule 3 111292719-111665750 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066754 Uncertain Tissue enhanced 0 lymph node: 21.1 tonsil: 15.6 CD97 TM7LN1 ENSG00000123146 CD97 molecule 19 14380501-14408725 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013707 Supportive Uncertain Cytoplasm Expressed in all bone marrow: 104.5 CD99 MIC2 ENSG00000002586 CD99 molecule X 2691179-2741309 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000020, HPA035304 Supportive Uncertain Golgi apparatus Expressed in all gallbladder: 239.4 CDCP1 CD318, SIMA135 ENSG00000163814 CUB domain containing protein 1 3 45082278-45146422 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010978, HPA010979, CAB025637 Supportive Mixed esophagus: 17.9 CDH1 CD324, UVO, uvomorulin ENSG00000039068 Cadherin 1, type 1, E-cadherin (epithelial) 16 68737225-68835548 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857 Supportive Supportive Plasma membrane, Golgi apparatus, Vesicles, Focal Adhesions Mixed thyroid gland: 127.2 CDH2 CD325, CDHN, NCAD ENSG00000170558 Cadherin 2, type 1, N-cadherin (neuronal) 18 27950966-28177446 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000141, CAB018580, HPA058574 Supportive Supportive Plasma membrane, Cell Junctions Tissue enhanced 0 adrenal gland: 57.8;heart muscle: 105.4 testis: 40.1 CDH5 7B4, CD144 ENSG00000179776 Cadherin 5, type 2 (vascular endothelium) 16 66366622-66404786 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB028366, HPA030562 Uncertain Tissue enhanced 0 placenta: 153.3 lung: 82.6 CEACAM1 BGP, BGP1, CD66a ENSG00000079385 Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) 19 42507304-42561234 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002146, HPA011041 Supportive Tissue enhanced 0 colon: 183.4;rectum: 127.1 esophagus: 36.8 CEACAM3 CD66d, CGM1 ENSG00000170956 Carcinoembryonic antigen-related cell adhesion molecule 3 19 41796437-41811553 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA011041 Uncertain Tissue enriched 7 bone marrow: 15.1 appendix: 2.0 CEACAM5 CD66e, CEA ENSG00000105388 Carcinoembryonic antigen-related cell adhesion molecule 5 19 41576273-41729798 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000021, CAB000022, HPA011041, HPA019758 Supportive Tissue enhanced 0 colon: 966.5;rectum: 934.6 appendix: 219.1 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supportive Group enriched 6 bone marrow: 90.3;colon: 164.9;esophagus: 125.4;gallbladder: 120.4;lung: 194.9;rectum: 174.6 tonsil: 25.5 CEACAM8 CD66b, CGM6 ENSG00000124469 Carcinoembryonic antigen-related cell adhesion molecule 8 19 42580241-42740384 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033676 Uncertain Tissue enriched 94 bone marrow: 115.7 lung: 1.2 CLEC10A CD301, CLECSF13, CLECSF14, HML, HML2 ENSG00000132514 C-type lectin domain family 10, member A 17 7074537-7080307 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA021937 Uncertain Mixed appendix: 25.6 CLEC4C BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL ENSG00000198178 C-type lectin domain family 4, member C 12 7729415-7751605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029432 Uncertain Tissue enhanced 0 lymph node: 3.4;tonsil: 3.4 spleen: 1.9 CLEC4M CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN ENSG00000104938 C-type lectin domain family 4, member M 19 7763149-7769605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033689, CAB033691, HPA042661 Supportive Group enriched 8 liver: 20.0;lymph node: 13.8;placenta: 8.6 ovary: 1.7 CR1 CD35, KN ENSG00000203710 Complement component (3b/4b) receptor 1 (Knops blood group) 1 207496147-207640647 Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002491, CAB016271, HPA042455, HPA043579, HPA049348 Supportive Uncertain Tissue enhanced 0 appendix: 18.9;spleen: 15.9 lymph node: 13.3 CR2 CD21 ENSG00000117322 Complement component (3d/Epstein Barr virus) receptor 2 1 207454230-207489895 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002659, HPA052942, HPA060715 Supportive Group enriched 15 appendix: 47.0;lymph node: 145.4;spleen: 62.0;tonsil: 141.4 stomach: 6.7 CRTAM CD355 ENSG00000109943 Cytotoxic and regulatory T cell molecule 11 122838500-122872639 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054595 Uncertain Tissue enhanced 0 lymph node: 8.4 tonsil: 3.1 CSF1R C-FMS, CD115, CSFR, FMS ENSG00000182578 Colony stimulating factor 1 receptor 5 150053291-150113372 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB008970, HPA012323 Uncertain Mixed spleen: 91.1 CSF2RA CD116, CSF2R ENSG00000198223 Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) X 1268800-1310381 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB016148 Uncertain Tissue enhanced 0 placenta: 59.8 appendix: 21.6 CSF2RB CD131, IL3RB, IL5RB ENSG00000100368 Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) 22 36913628-36940449 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010251 Uncertain Tissue enhanced 0 appendix: 56.5;tonsil: 51.6 lymph node: 32.5 CSF3R CD114, GCSFR ENSG00000119535 Colony stimulating factor 3 receptor (granulocyte) 1 36466043-36483278 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB017116, HPA048086 Supportive Tissue enhanced 0 appendix: 129.5;bone marrow: 209.9;placenta: 107.7 spleen: 65.5 CXCR1 CD181, CDw128a, CKR-1, CMKAR1, IL8RA ENSG00000163464 Chemokine (C-X-C motif) receptor 1 2 218162845-218166995 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031991 Uncertain Tissue enhanced 0 appendix: 23.1;spleen: 13.3 adipose tissue: 9.4 CXCR2 CD182, CMKAR2, IL8RB ENSG00000180871 Chemokine (C-X-C motif) receptor 2 2 218125289-218137253 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016268, HPA031999, HPA032017 Supportive Tissue enhanced 0 appendix: 33.0;esophagus: 22.4 spleen: 20.6 CXCR3 CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR ENSG00000186810 Chemokine (C-X-C motif) receptor 3 X 71615916-71618517 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045942 Supportive Tissue enhanced 0 lymph node: 12.5 spleen: 6.0 CXCR5 BLR1, CD185, MDR15 ENSG00000160683 Chemokine (C-X-C motif) receptor 5 11 118883766-118897799 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026149, HPA042432 Supportive Group enriched 5 appendix: 8.9;bone marrow: 5.2;lymph node: 23.2;spleen: 14.9;tonsil: 14.1 urinary bladder: 2.6 CXCR6 BONZO, CD186, STRL33, TYMSTR ENSG00000172215 Chemokine (C-X-C motif) receptor 6 3 45940933-45948353 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA047591 Uncertain Mixed lymph node: 14.6 DDR1 CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6 ENSG00000204580 Discoidin domain receptor tyrosine kinase 1 6 30876421-30900156 CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010162, CAB025656, HPA057194 Uncertain Uncertain Nucleus but not nucleoli, Cell Junctions Expressed in all fallopian tube: 126.6 DPP4 ADCP2, CD26, DPPIV ENSG00000197635 Dipeptidyl-peptidase 4 2 161992241-162074542 CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB045970 Supportive Tissue enhanced 0 small intestine: 92.9 placenta: 77.4 ENG CD105, END, HHT1, ORW, ORW1 ENSG00000106991 Endoglin 9 127815012-127854756 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000096, HPA011862, HPA067440, CAB072873 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all spleen: 111.7 ENPEP CD249, gp160 ENSG00000138792 Glutamyl aminopeptidase (aminopeptidase A) 4 110365733-110565285 CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005128 Uncertain Tissue enhanced 0 kidney: 62.9;small intestine: 130.2 duodenum: 28.1 ENPP1 M6S1, NPPS, PC-1, PCA1, PDNP1 ENSG00000197594 Ectonucleotide pyrophosphatase/phosphodiesterase 1 6 131808016-131895155 CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032904, HPA062066 Supportive Tissue enhanced 0 placenta: 25.0 thyroid gland: 16.2 ENPP3 B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3 ENSG00000154269 Ectonucleotide pyrophosphatase/phosphodiesterase 3 6 131628442-131747418 CD markers, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043772 Uncertain Tissue enhanced 0 small intestine: 35.4 duodenum: 12.3 ENTPD1 ATPDase, CD39, NTPDase-1, SPG64 ENSG00000138185 Ectonucleoside triphosphate diphosphohydrolase 1 10 95711779-95877266 CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002494, HPA014067 Supportive Uncertain Cytoskeleton (Microtubules) Mixed smooth muscle: 59.7 EPCAM 17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1 ENSG00000119888 Epithelial cell adhesion molecule 2 47345158-47387601 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003809, HPA026761, CAB030012 Supportive Uncertain Nuclear membrane Tissue enhanced 0 colon: 479.4;rectum: 440.4;small intestine: 407.9 duodenum: 374.0 ERBB2 CD340, HER-2, HER2, NEU, NGL ENSG00000141736 V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 17 39687914-39730426 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000043, HPA001338, HPA001383, CAB020416, CAB062555 Uncertain Supportive Nucleus, Plasma membrane, Cytoplasm Expressed in all esophagus: 69.5 EVI2B CD361, D17S376, EVDB ENSG00000185862 Ecotropic viral integration site 2B 17 31303766-31314112 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007436, HPA053383 Uncertain Uncertain Nuclear membrane, Nucleus, Vesicles Mixed tonsil: 139.6 F11R CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1 ENSG00000158769 F11 receptor 1 160995211-161021348 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004671, HPA043616, HPA061700 Supportive Uncertain Cytoskeleton (Microtubules), Cell Junctions Expressed in all lung: 64.9 F3 CD142 ENSG00000117525 Coagulation factor III (thromboplastin, tissue factor) 1 94529225-94541800 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009438, HPA049292 Uncertain Supportive Vesicles Expressed in all placenta: 90.9 FAS APO-1, APT1, CD95, FAS1, TNFRSF6 ENSG00000026103 Fas cell surface death receptor 10 88990531-89015785 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027444 Uncertain Supportive Plasma membrane, Cytoplasm Mixed rectum: 26.9 FASLG APT1LG1, CD178, FasL, TNFSF6 ENSG00000117560 Fas ligand (TNF superfamily, member 6) 1 172659018-172666874 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA054959 Uncertain Tissue enhanced 0 lymph node: 4.1 spleen: 2.6 FCAR CD89 ENSG00000186431 Fc fragment of IgA, receptor for 19 54874248-54890472 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014050 Uncertain Supportive Plasma membrane Tissue enriched 13 bone marrow: 296.6 appendix: 23.1 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Supportive Uncertain Nucleus but not nucleoli Group enriched 9 appendix: 14.8;lymph node: 33.6;spleen: 37.4;tonsil: 35.5 adipose tissue: 3.2 FCGR2A CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2 ENSG00000143226 Fc fragment of IgG, low affinity IIa, receptor (CD32) 1 161505430-161524013 CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010718, HPA014730 Supportive Mixed appendix: 80.9 FCGR2B CD32, CD32B, FCG2, FCGR2 ENSG00000072694 Fc fragment of IgG, low affinity IIb, receptor (CD32) 1 161581311-161678654 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007796, HPA014730 Supportive Tissue enriched 8 placenta: 170.4 tonsil: 20.1 FCGR3A CD16, CD16a, FCG3, FCGR3 ENSG00000203747 Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 1 161541759-161550737 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032435, HPA055431 Supportive Expressed in all spleen: 203.8 FCRL1 CD307a, FCRH1, IFGP1, IRTA5 ENSG00000163534 Fc receptor-like 1 1 157794403-157820105 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013323 Supportive Tissue enhanced 0 lymph node: 22.0;spleen: 17.1;tonsil: 19.0 appendix: 9.1 FCRL2 CD307b, FCRH2, IRTA4, SPAP1 ENSG00000132704 Fc receptor-like 2 1 157745733-157777132 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB017619, HPA041426 Uncertain Group enriched 8 appendix: 9.9;lymph node: 19.0;spleen: 15.1;tonsil: 19.7 urinary bladder: 2.0 FCRL3 CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e ENSG00000160856 Fc receptor-like 3 1 157674321-157700857 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015508 Uncertain Group enriched 11 appendix: 12.8;lymph node: 41.7;spleen: 22.8;tonsil: 29.5 urinary bladder: 2.3 FCRL4 CD307d, FCRH4, IGFP2, IRTA1 ENSG00000163518 Fc receptor-like 4 1 157573749-157598080 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054030 Uncertain Group enriched 9 appendix: 2.7;lymph node: 3.3;tonsil: 8.9 spleen: 0.5 FGFR1 BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM ENSG00000077782 Fibroblast growth factor receptor 1 8 38411138-38468834 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033614, HPA056402 Uncertain Expressed in all ovary: 70.5 FGFR2 BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 ENSG00000066468 Fibroblast growth factor receptor 2 10 121478334-121598458 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010886, HPA035305, HPA056562 Uncertain Supportive Vesicles, Cell Junctions, Nucleus Mixed skin: 56.0 FGFR3 ACH, CD333, CEK2, JTK4 ENSG00000068078 Fibroblast growth factor receptor 3 4 1793307-1808872 Cancer-related genes, CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004231, HPA067204 Supportive Supportive Endoplasmic reticulum Tissue enriched 7 skin: 195.8 esophagus: 26.9 FGFR4 CD334, JTK2 ENSG00000160867 Fibroblast growth factor receptor 4 5 177086886-177098144 Cancer-related genes, CD markers, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005196, HPA027273, HPA027369, HPA028251 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 lung: 28.1 kidney: 18.0 FLT3 CD135, FLK2, STK1 ENSG00000122025 Fms-related tyrosine kinase 3 13 28003274-28100592 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB018358 Uncertain Tissue enhanced 0 lymph node: 5.9;spleen: 5.5 tonsil: 3.2 FZD10 CD350 ENSG00000111432 Frizzled class receptor 10 12 130162459-130165740 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014484, HPA014485 Uncertain Supportive Nucleus but not nucleoli Tissue enhanced 0 esophagus: 6.6 skin: 3.4 FZD4 CD344, EVR1 ENSG00000174804 Frizzled class receptor 4 11 86945679-86955391 CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042328 Uncertain Tissue enhanced 0 adipose tissue: 86.3 kidney: 18.4 GGT1 CD224, D22S672, D22S732, GGT ENSG00000100031 Gamma-glutamyltransferase 1 22 24583750-24629005 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045635, HPA047534 Supportive Tissue enhanced 0 kidney: 116.9 duodenum: 54.7 GP1BA CD42b, GP1B ENSG00000185245 Glycoprotein Ib (platelet), alpha polypeptide 17 4932297-4935030 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002496, HPA013316 Supportive Uncertain Cytoplasm, Centrosome Tissue enhanced 0 lymph node: 12.2;tonsil: 6.6 spleen: 3.5 GP9 CD42a, GPIX ENSG00000169704 Glycoprotein IX (platelet) 3 129060767-129062406 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063182 Supportive Tissue enhanced 0 bone marrow: 2.3;spleen: 1.7 lung: 0.6 GYPA CD235a, GPA, MN, MNS ENSG00000170180 Glycophorin A (MNS blood group) 4 144109303-144140751 Blood group antigen proteins, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002658, HPA014811 Supportive Uncertain Cytoplasm, Nucleus but not nucleoli Tissue enriched 36 bone marrow: 93.9 placenta: 2.6 GYPC CD236, CD236R, Ge, GPC, GYPD ENSG00000136732 Glycophorin C (Gerbich blood group) 2 126655933-126696675 Blood group antigen proteins, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008965, CAB009445 Supportive Uncertain Cytoplasm, Vesicles Expressed in all bone marrow: 200.2 HMMR CD168, RHAMM ENSG00000072571 Hyaluronan-mediated motility receptor (RHAMM) 5 163460203-163491945 CD markers, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002433, HPA040025, HPA043926 Supportive Supportive Cytoskeleton (Microtubules), Centrosome Tissue enhanced 0 testis: 22.2 lymph node: 15.9 ICAM1 BB2, CD54 ENSG00000090339 Intercellular adhesion molecule 1 19 10270835-10286615 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002126, CAB002142, HPA004877 Supportive Uncertain Plasma membrane, Cytoplasm Expressed in all lung: 116.8 ICAM2 CD102 ENSG00000108622 Intercellular adhesion molecule 2 17 64002594-64020634 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002020 Uncertain Expressed in all spleen: 135.3 ICAM3 CD50, CDW50, ICAM-R ENSG00000076662 Intercellular adhesion molecule 3 19 10333776-10339823 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002498, HPA049820 Supportive Uncertain Nucleus, Nuclear membrane, Mitochondria Expressed in all bone marrow: 101.3 ICAM4 CD242, LW ENSG00000105371 Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) 19 10286967-10288522 Blood group antigen proteins, CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA067629 Uncertain Nucleus but not nucleoli Tissue enhanced 0 bone marrow: 6.5;lung: 6.2 placenta: 1.8 ICOS AILIM, CD278 ENSG00000163600 Inducible T-cell co-stimulator 2 203936748-203961577 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032575 Uncertain Tissue enhanced 0 lymph node: 11.7;tonsil: 13.1 bone marrow: 8.5 ICOSLG B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653 ENSG00000160223 Inducible T-cell co-stimulator ligand 21 44222991-44240966 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026037 Uncertain Supportive Mitochondria Mixed lymph node: 5.5 IFITM1 9-27, CD225, IFI17 ENSG00000185885 Interferon induced transmembrane protein 1 11 313506-315272 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004810, CAB017615 Supportive Supportive Cytoplasm Expressed in all fallopian tube: 316.1 IFNGR1 CD119, IFNGR ENSG00000027697 Interferon gamma receptor 1 6 137197484-137219449 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004444, HPA029213, HPA063871 Uncertain Uncertain Vesicles, Cytoplasm Expressed in all spleen: 130.8 IGF1R CD221, IGFIR, IGFR, JTK13, MGC18216 ENSG00000140443 Insulin-like growth factor 1 receptor 15 98648971-98964530 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010268, HPA045563 Uncertain Uncertain Vesicles Expressed in all fallopian tube: 15.3 IGF2R CD222, CIMPR, M6P-R, MPR1, MPRI ENSG00000197081 Insulin-like growth factor 2 receptor 6 159969099-160113507 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009661, HPA011332 Supportive Supportive Golgi apparatus, Vesicles Expressed in all spleen: 27.5 IGSF8 CD316, CD81P3, EWI2, PGRL ENSG00000162729 Immunoglobulin superfamily, member 8 1 160091340-160098943 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011917 Uncertain Expressed in all cerebral cortex: 47.7 IL10RA CD210, CD210a, CDW210A, HIL-10R, IL10R ENSG00000110324 Interleukin 10 receptor, alpha 11 117986348-118001483 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071295 Uncertain Mixed spleen: 50.3 IL10RB CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2 ENSG00000243646 Interleukin 10 receptor, beta 21 33266358-33297234 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB020670, HPA047550 Uncertain Uncertain Cytoplasm Expressed in all placenta: 54.9 IL13RA1 CD213a1, IL-13Ra, NR4 ENSG00000131724 Interleukin 13 receptor, alpha 1 X 118727572-118794539 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000293, HPA001008, HPA001587, HPA001795 Supportive Uncertain Nucleus but not nucleoli, Golgi apparatus Expressed in all rectum: 51.1 IL13RA2 CD213a2, CT19, IL-13R, IL13BP ENSG00000123496 Interleukin 13 receptor, alpha 2 X 115003975-115019977 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055552 Uncertain Nucleoli, Nucleus Tissue enriched 6 testis: 23.9 adrenal gland: 4.0 IL15RA CD215, IL-15RA ENSG00000134470 Interleukin 15 receptor, alpha 10 5937569-5978187 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026215 Uncertain Uncertain Plasma membrane, Cytoplasm Expressed in all lung: 13.8 IL17RA CD217, CDw217, hIL-17R, IL-17RA, IL17R ENSG00000177663 Interleukin 17 receptor A 22 17084954-17115694 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB024996 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Mixed bone marrow: 14.9 IL18R1 CD218a, IL-1Rrp, IL1RRP ENSG00000115604 Interleukin 18 receptor 1 2 102311529-102398775 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007615 Uncertain Uncertain Mitochondria Mixed appendix: 7.4 IL18RAP AcPL, CD218b ENSG00000115607 Interleukin 18 receptor accessory protein 2 102418689-102452565 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025270 Uncertain Tissue enhanced 0 bone marrow: 34.5 appendix: 9.1 IL1R1 CD121A, D2S1473, IL1R, IL1RA ENSG00000115594 Interleukin 1 receptor, type I 2 102064544-102179874 Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005823, CAB007779, HPA029560 Uncertain Expressed in all gallbladder: 89.2 IL1R2 CD121b, IL1RB ENSG00000115590 Interleukin 1 receptor, type II 2 101991844-102028544 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027597, HPA027598 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Mixed rectum: 35.2 IL21R CD360 ENSG00000103522 Interleukin 21 receptor 16 27402162-27452042 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042296 Uncertain Uncertain Plasma membrane, Cytoplasm Tissue enhanced 0 lymph node: 19.9;tonsil: 15.7 appendix: 10.0 IL2RA CD25, IDDM10, IL2R ENSG00000134460 Interleukin 2 receptor, alpha 10 6010689-6062325 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002419, HPA054622 Supportive Tissue enhanced 0 adipose tissue: 14.8;lymph node: 15.2 appendix: 12.0 IL2RB CD122, IL15RB ENSG00000100385 Interleukin 2 receptor, beta 22 37125838-37175054 Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051627, HPA062657 Supportive Uncertain Nucleus, Nucleoli Tissue enhanced 0 spleen: 45.6 lymph node: 29.2 IL2RG CD132, CIDX, IMD4, SCIDX1 ENSG00000147168 Interleukin 2 receptor, gamma X 71107404-71112108 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046641 Supportive Tissue enhanced 0 lymph node: 219.7;tonsil: 264.8 appendix: 125.4 IL3RA CD123 ENSG00000185291 Interleukin 3 receptor, alpha (low affinity) X 1336616-1382689 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003539, CAB018374 Uncertain Expressed in all lymph node: 14.1 IL4R CD124 ENSG00000077238 Interleukin 4 receptor 16 27313668-27364778 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004451, HPA050124 Supportive Uncertain Cytoplasm Expressed in all lymph node: 78.0 IL6ST CD130, GP130 ENSG00000134352 Interleukin 6 signal transducer 5 55935095-55994993 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010558, CAB025784 Uncertain Supportive Plasma membrane, Golgi apparatus Expressed in all placenta: 134.1 IL7R CD127 ENSG00000168685 Interleukin 7 receptor 5 35852695-35879603 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010215 Uncertain Supportive Plasma membrane Tissue enhanced 0 appendix: 122.1;lymph node: 113.5 tonsil: 99.7 IL9R CD129 ENSG00000124334 Interleukin 9 receptor X 155997581-156010817 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010497 Uncertain Tissue enhanced 0 urinary bladder: 3.4 lymph node: 0.9 INSR CD220 ENSG00000171105 Insulin receptor 19 7112255-7294034 CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036302, HPA036303 Uncertain Supportive Vesicles Expressed in all ovary: 24.6 ITGA1 CD49a, VLA1 ENSG00000213949 Integrin, alpha 1 5 52787896-52959210 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042555 Uncertain Mixed spleen: 42.7 ITGA2 CD49B ENSG00000164171 Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 5 52989326-53094779 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017690, HPA060991, HPA063556 Supportive Mixed skin: 12.2 ITGA2B CD41, CD41B, GP2B, PPP1R93 ENSG00000005961 Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) 17 44372180-44389505 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018611, HPA031168, HPA031169, HPA031170, HPA031171 Supportive Supportive Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 bone marrow: 9.0 thyroid gland: 2.5 ITGA3 CD49c, GAP-B3, MSK18, VCA-2, VLA3a ENSG00000005884 Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) 17 50055968-50090481 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008572, CAB018594 Supportive Supportive Plasma membrane, Golgi apparatus Mixed lung: 70.2 ITGA5 CD49e, FNRA ENSG00000161638 Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 12 54395261-54419460 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002642, CAB009008 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm, Golgi apparatus Expressed in all smooth muscle: 291.5 ITGA6 CD49f ENSG00000091409 Integrin, alpha 6 2 172427354-172506282 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009009, HPA012696, HPA027582 Supportive Expressed in all placenta: 62.5 ITGAD ADB2, CD11d ENSG00000156886 Integrin, alpha D 16 31393312-31426505 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA026786 Uncertain Group enriched 7 lymph node: 3.2;spleen: 15.9 bone marrow: 1.4 ITGAE CD103, HUMINAE ENSG00000083457 Integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) 17 3714628-3801243 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026461, HPA036313, HPA052147 Supportive Supportive Nucleus but not nucleoli, Vesicles Mixed small intestine: 3.9 ITGAL CD11A, LFA-1 ENSG00000005844 Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) 16 30472658-30523185 CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025011 Supportive Tissue enhanced 0 lymph node: 57.8;spleen: 51.6 tonsil: 41.3 ITGAM CD11B, CR3A, MAC-1 ENSG00000169896 Integrin, alpha M (complement component 3 receptor 3 subunit) 16 31259990-31332892 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002274, CAB025091, CAB072870 Supportive Tissue enhanced 0 bone marrow: 100.7 appendix: 22.7 ITGAV CD51, MSK8, VNRA, VTNR ENSG00000138448 Integrin, alpha V 2 186590065-186680901 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002499, HPA004856 Supportive Uncertain Cytoplasm, Focal Adhesions Expressed in all thyroid gland: 59.5 ITGAX CD11C ENSG00000140678 Integrin, alpha X (complement component 3 receptor 4 subunit) 16 31355134-31382997 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004458, HPA004723, CAB072871 Supportive Uncertain Cytoplasm Tissue enhanced 0 appendix: 36.4;spleen: 39.8 bone marrow: 22.2 ITGB1 CD29, FNRB, GPIIA, MDF2, MSK12 ENSG00000150093 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 10 32900319-33005792 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003434 Uncertain Supportive Plasma membrane, Focal Adhesions, Endoplasmic reticulum Expressed in all smooth muscle: 448.9 ITGB2 CD18, LFA-1, MAC-1, MFI7 ENSG00000160255 Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 21 44885953-44931989 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008877, HPA016894 Supportive Uncertain Nucleus Expressed in all bone marrow: 185.3 ITGB3 CD61, GP3A, GPIIIa ENSG00000259207 Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 17 47253846-47311816 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027852 Supportive Tissue enhanced 0 thyroid gland: 44.4 smooth muscle: 19.9 ITGB4 CD104 ENSG00000132470 Integrin, beta 4 17 75721328-75757818 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002422, CAB005258, HPA036348, HPA036349 Supportive Supportive Plasma membrane, Cell Junctions, Nucleus Expressed in all skin: 67.2 JAG1 AGS, AHD, AWS, CD339, HJ1, JAGL1 ENSG00000101384 Jagged 1 20 10637684-10674107 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010343, HPA021555 Supportive Supportive Plasma membrane, Golgi apparatus Expressed in all placenta: 42.8 KDR CD309, FLK1, VEGFR, VEGFR2 ENSG00000128052 Kinase insert domain receptor (a type III receptor tyrosine kinase) 4 55078477-55125589 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004028, HPA030893 Uncertain Uncertain Nucleus but not nucleoli Tissue enhanced 0 placenta: 61.4 thyroid gland: 32.2 KEL CD238, ECE3 ENSG00000197993 Kell blood group, metallo-endopeptidase 7 142941114-142962681 Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042391 Uncertain Tissue enhanced 0 bone marrow: 22.3;testis: 22.3 lymph node: 8.4 KIT C-Kit, CD117, PBT, SCFR ENSG00000157404 V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 4 54657918-54740715 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003288, HPA004471, CAB068253, CAB072867 Supportive Mixed thyroid gland: 41.1 KLRB1 CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A ENSG00000111796 Killer cell lectin-like receptor subfamily B, member 1 12 9594551-9607886 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA039113 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Mixed tonsil: 26.9 KLRD1 CD94 ENSG00000134539 Killer cell lectin-like receptor subfamily D, member 1 12 10226058-10329600 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069688 Uncertain Tissue enhanced 0 spleen: 14.8 lymph node: 5.6 KLRK1 CD314, D12S2489E, KLR, NKG2-D, NKG2D ENSG00000213809 Killer cell lectin-like receptor subfamily K, member 1 12 10372353-10391874 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB021896 Supportive Tissue enhanced 0 lymph node: 28.2;spleen: 30.4 tonsil: 14.4 L1CAM CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1 ENSG00000198910 L1 cell adhesion molecule X 153861514-153909223 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005830, CAB010896 Supportive Supportive Nucleus but not nucleoli, Plasma membrane Tissue enhanced 0 adrenal gland: 20.6;cerebral cortex: 31.3 kidney: 12.3 LAG3 CD223 ENSG00000089692 Lymphocyte-activation gene 3 12 6772512-6778455 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002301, HPA013967 Supportive Uncertain Tissue enhanced 0 spleen: 22.4 lymph node: 13.3 LAIR1 CD305 ENSG00000167613 Leukocyte-associated immunoglobulin-like receptor 1 19 54351384-54370558 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011155 Supportive Supportive Plasma membrane Expressed in all bone marrow: 54.7 LAMP1 CD107a ENSG00000185896 Lysosomal-associated membrane protein 1 13 113297241-113323672 CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004260, HPA014750 Supportive Expressed in all thyroid gland: 125.0 LAMP2 CD107b ENSG00000005893 Lysosomal-associated membrane protein 2 X 120427827-120469365 CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005272, HPA029100 Supportive Uncertain Cytoskeleton (Intermediate filaments) Expressed in all gallbladder: 138.2 LAMP3 CD208, DC-LAMP, DCLAMP, LAMP, TSC403 ENSG00000078081 Lysosomal-associated membrane protein 3 3 183122213-183163839 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025133, HPA051467 Supportive Tissue enriched 6 lung: 190.1 appendix: 29.7 LEPR CD295, OBR ENSG00000116678 Leptin receptor 1 65420652-65641559 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030899 Uncertain Uncertain Vesicles Mixed liver: 40.3 LIFR CD118 ENSG00000113594 Leukemia inhibitory factor receptor alpha 5 38474963-38608354 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004478, CAB010252, HPA064147 Uncertain Supportive Nucleus but not nucleoli Mixed adipose tissue: 35.9 LILRA4 CD85g, ILT7 ENSG00000239961 Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 19 54333185-54339150 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048255, HPA049418 Uncertain Tissue enhanced 0 lymph node: 6.8;spleen: 6.9;tonsil: 6.7 appendix: 1.8 LILRB4 CD85k, HM18, ILT3, LIR-5, LIR5 ENSG00000186818 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 19 54643889-54670359 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052807 Uncertain Tissue enhanced 0 lymph node: 37.4 appendix: 34.9 LILRB5 CD85c, LIR-8, LIR8 ENSG00000105609 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 19 54249431-54257301 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012069 Uncertain Uncertain Cytoplasm Tissue enhanced 0 spleen: 28.8 adipose tissue: 15.4 LRP1 A2MR, APOER, APR, CD91, LRP, LRP1A ENSG00000123384 Low density lipoprotein receptor-related protein 1 12 57128493-57213351 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004182, CAB018621, HPA022903 Supportive Supportive Nucleoli, Cytoplasm Expressed in all adipose tissue: 77.6 LY75 CD205, CLEC13B, DEC-205 ENSG00000054219 Lymphocyte antigen 75 2 159803355-159904749 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001450, HPA049108, HPA054073 Uncertain Uncertain Golgi apparatus Mixed lymph node: 26.7 LY9 CD229, hly9, mLY9, SLAMF3 ENSG00000122224 Lymphocyte antigen 9 1 160796074-160828261 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050917 Uncertain Tissue enhanced 0 lymph node: 23.0;tonsil: 24.5 spleen: 16.5 MCAM CD146, MUC18 ENSG00000076706 Melanoma cell adhesion molecule 11 119308529-119321521 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002147, HPA008848 Supportive Supportive Plasma membrane Expressed in all adipose tissue: 241.7 MFI2 CD228, FLJ38863, MAP97, MGC4856, MTF1 ENSG00000163975 Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 3 196988621-197029816 CD markers, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004880 Uncertain Tissue enhanced 0 salivary gland: 27.9 kidney: 6.5 MME CALLA, CD10, NEP ENSG00000196549 Membrane metallo-endopeptidase 3 155024124-155183729 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000013, HPA052583, HPA056072 Supportive Tissue enhanced 0 duodenum: 291.0;kidney: 235.4;small intestine: 256.5 placenta: 82.8 MPL CD110, TPOR ENSG00000117400 MPL proto-oncogene, thrombopoietin receptor 1 43337807-43352772 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002011, HPA007619 Supportive Plasma membrane Not detected ovary: 0.4 MRC1 bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1 ENSG00000260314 Mannose receptor, C type 1 10 17809344-17911170 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA004114, HPA045134, CAB068203 Supportive Mixed lung: 68.7 MRC2 CD280, CLEC13E, ENDO180, KIAA0709 ENSG00000011028 Mannose receptor, C type 2 17 62627401-62693597 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041991 Supportive Expressed in all gallbladder: 23.8 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supportive Group enriched 13 appendix: 176.9;lymph node: 562.2;spleen: 290.3;tonsil: 731.0 urinary bladder: 33.2 MSR1 CD204, SCARA1 ENSG00000038945 Macrophage scavenger receptor 1 8 16107878-16567490 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000272, CAB032491 Supportive Tissue enhanced 0 lung: 76.6 gallbladder: 28.3 MST1R CD136, CDw136, PTK8, RON ENSG00000164078 Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) 3 49887002-49903873 CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007657, HPA008180, CAB008972 Uncertain Uncertain Cytoplasm Tissue enhanced 0 skin: 45.6 stomach: 26.1 MUC1 ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM ENSG00000185499 Mucin 1, cell surface associated 1 155185824-155192916 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000036, CAB001986, HPA004179, HPA007235, HPA008855 Supportive Supportive Plasma membrane, Vesicles Tissue enhanced 0 stomach: 469.1 lung: 225.8 NCAM1 CD56, NCAM ENSG00000149294 Neural cell adhesion molecule 1 11 112961247-113278436 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000142, CAB018071, HPA039835 Supportive Supportive Plasma membrane, Cytoplasm Tissue enhanced 0 cerebral cortex: 132.0 heart muscle: 69.5 NCR2 CD336, LY95, NK-p44 ENSG00000096264 Natural cytotoxicity triggering receptor 2 6 41335655-41350887 CD markers, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level HPA067249 Uncertain Not detected duodenum: 0.4 NGFR CD271, p75NTR, TNFRSF16 ENSG00000064300 Nerve growth factor receptor 17 49495293-49515017 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000143, CAB001995, HPA004765 Supportive Uncertain Nucleus but not nucleoli, Plasma membrane Mixed adipose tissue: 19.5 NRP1 CD304, NRP, VEGF165R ENSG00000099250 Neuropilin 1 10 33177492-33336262 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004511, HPA030278 Supportive Uncertain Mitochondria Expressed in all placenta: 105.1 NT5E CALJA, CD73, eN, eNT, NT5 ENSG00000135318 5'-nucleotidase, ecto (CD73) 6 85449584-85495791 CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017357 Uncertain Supportive Plasma membrane, Cytoplasm Mixed smooth muscle: 63.5 PDCD1 CD279, hSLE1, PD1, SLEB2 ENSG00000188389 Programmed cell death 1 2 241849881-241858908 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035981, CAB038418 Supportive Tissue enhanced 0 lymph node: 14.0 tonsil: 3.8 PDCD1LG2 B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2 ENSG00000197646 Programmed cell death 1 ligand 2 9 5510570-5571254 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013411 Uncertain Uncertain Cytoplasm Mixed spleen: 10.6 PDGFRA CD140a, PDGFR2 ENSG00000134853 Platelet-derived growth factor receptor, alpha polypeptide 4 54229097-54298247 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB018143 Uncertain Tissue enhanced 0 ovary: 148.6 urinary bladder: 39.8 PDGFRB CD140b, JTK12, PDGFR, PDGFR1 ENSG00000113721 Platelet-derived growth factor receptor, beta polypeptide 5 150113837-150155872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003842, CAB018144, HPA028499 Supportive Uncertain Cytoplasm, Vesicles Mixed gallbladder: 125.2 PLAUR CD87, UPAR, URKR ENSG00000011422 Plasminogen activator, urokinase receptor 19 43646095-43670547 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050843, CAB073533 Uncertain Supportive Plasma membrane Tissue enhanced 0 bone marrow: 379.5 gallbladder: 77.2 PLXNC1 CD232, VESPR ENSG00000136040 Plexin C1 12 94148723-94307675 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB026155 Uncertain Mixed appendix: 18.1 PRNP AltPrP, CD230, CJD, GSS, PRIP, PRP ENSG00000171867 Prion protein 20 4686236-4701590 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042754, HPA043398 Supportive Uncertain Nuclear membrane, Cytoplasm, Vesicles Expressed in all cerebral cortex: 317.4 PROCR CCD41, CD201, EPCR ENSG00000101000 Protein C receptor, endothelial 20 35172073-35177362 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039461 Supportive Uncertain Nucleus, Cytoplasm Mixed adipose tissue: 33.5 PROM1 AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4 ENSG00000007062 Prominin 1 4 15963076-16084378 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004922, CAB011525, HPA031053 Supportive Uncertain Vesicles Mixed gallbladder: 31.0 PSG1 CD66f, PBG1, PSBG1, PSGGA ENSG00000231924 Pregnancy specific beta-1-glycoprotein 1 19 42866464-42879822 CD markers, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046327 Uncertain Tissue enriched 595 placenta: 377.0 smooth muscle: 0.6 PTGDR2 CD294, CRTH2, DP2, GPR44 ENSG00000183134 Prostaglandin D2 receptor 2 11 60850940-60855971 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA014259 Uncertain Tissue enhanced 0 stomach: 6.6 small intestine: 4.6 PTGFRN CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6 ENSG00000134247 Prostaglandin F2 receptor inhibitor 1 116910057-116990358 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017074 Uncertain Uncertain Cytoskeleton (Cytokinetic bridge) Mixed smooth muscle: 40.4 PTPRJ CD148, DEP1, HPTPeta ENSG00000149177 Protein tyrosine phosphatase, receptor type, J 11 47980558-48170841 CD markers, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006026 Uncertain Mixed thyroid gland: 19.3 PVR CD155, HVED, Necl-5, NECL5, PVS, Tage4 ENSG00000073008 Poliovirus receptor 19 44643798-44663583 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012568 Uncertain Uncertain Nucleus but not nucleoli, Plasma membrane, Vesicles Expressed in all placenta: 10.1 PVRL1 CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRR1, SK-12 ENSG00000110400 Poliovirus receptor-related 1 (herpesvirus entry mediator C) 11 119623408-119729084 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016135, HPA026846 Uncertain Uncertain Nucleus Tissue enhanced 0 esophagus: 80.3;skin: 96.6 urinary bladder: 30.2 PVRL2 CD112, HVEB, PRR2, PVRR2 ENSG00000130202 Poliovirus receptor-related 2 (herpesvirus entry mediator B) 19 44846175-44889228 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012759, CAB026138 Supportive Expressed in all placenta: 59.5 PVRL3 CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRR3 ENSG00000177707 Poliovirus receptor-related 3 3 111070071-111275563 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009869, HPA011038, HPA052242 Supportive Supportive Microtubule organizing center, Centrosome, Nucleus, Cell Junctions Mixed testis: 43.5 RHAG CD241, RH50A, SLC42A1 ENSG00000112077 Rh-associated glycoprotein 6 49605158-49636839 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055331 Uncertain Tissue enriched 50 bone marrow: 58.6 placenta: 1.1 S1PR1 CD363, D1S3362, edg-1, EDG1 ENSG00000170989 Sphingosine-1-phosphate receptor 1 1 101236888-101241518 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010104 Uncertain Expressed in all adipose tissue: 57.0 SDC1 CD138, SDC, SYND1, syndecan ENSG00000115884 Syndecan 1 2 20200797-20225433 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002424, HPA006185 Supportive Supportive Focal Adhesions, Cytoplasm Mixed esophagus: 186.2 SDC2 CD362, fibroglycan, HSPG, HSPG1, SYND2 ENSG00000169439 Syndecan 2 8 96493351-96611780 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025123, HPA044416 Uncertain Uncertain Cytoplasm, Plasma membrane Expressed in all thyroid gland: 486.0 SELE CD62E, ELAM, ELAM1, ESEL ENSG00000007908 Selectin E 1 169722641-169764705 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002143 Supportive Tissue enhanced 0 prostate: 21.6;urinary bladder: 22.4 smooth muscle: 15.7 SELL CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR ENSG00000188404 Selectin L 1 169690667-169711698 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002144 Supportive Tissue enhanced 0 lymph node: 193.3;tonsil: 166.7 spleen: 125.8 SELP CD62, CD62P, GMP140, GRMP, PADGEM, PSEL ENSG00000174175 Selectin P (granule membrane protein 140kDa, antigen CD62) 1 169588849-169630193 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002145, HPA002655, HPA005990 Supportive Supportive Cytoplasm, Nucleus but not nucleoli Mixed urinary bladder: 15.2 SELPLG CD162, PSGL-1 ENSG00000110876 Selectin P ligand 12 108622277-108633959 Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002431 Supportive Expressed in all lymph node: 52.5 SEMA4D C9orf164, CD100, coll-4, FLJ39737, SEMAJ ENSG00000187764 Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D 9 89360787-89498130 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015662, HPA023277 Uncertain Supportive Vesicles, Endoplasmic reticulum Expressed in all lymph node: 54.0 SEMA7A CD108, H-Sema-L, SEMAL ENSG00000138623 Semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) 15 74409289-74434467 Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042273 Uncertain Tissue enhanced 0 spleen: 36.4;testis: 37.1 placenta: 30.8 SIGLEC1 CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN ENSG00000088827 Sialic acid binding Ig-like lectin 1, sialoadhesin 20 3686970-3707128 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053457 Supportive Mixed placenta: 13.8 SIGLEC5 CD170, CD33L2, OB-BP2, SIGLEC-5 ENSG00000105501 Sialic acid binding Ig-like lectin 5 19 51611503-51645545 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009085, CAB024900 Supportive Tissue enhanced 0 appendix: 6.2;bone marrow: 7.4 spleen: 5.4 SIGLEC6 CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6 ENSG00000105492 Sialic acid binding Ig-like lectin 6 19 51519525-51531856 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009084, HPA018198 Supportive Tissue enriched 28 placenta: 102.1 lung: 3.6 SIGLEC7 CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2 ENSG00000168995 Sialic acid binding Ig-like lectin 7 19 51142299-51153526 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025154 Uncertain Tissue enhanced 0 spleen: 11.7 appendix: 8.3 SIGLEC8 MGC59785, SAF2, SIGLEC-8, SIGLEC8L ENSG00000105366 Sialic acid binding Ig-like lectin 8 19 51450847-51458456 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012556 Uncertain Uncertain Cytoplasm Mixed lymph node: 5.5 SIRPA BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2 ENSG00000198053 Signal-regulatory protein alpha 20 1894167-1940592 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002776, CAB015122 Supportive Expressed in all cerebral cortex: 99.8 SIRPB1 CD172b, SIRP-BETA-1 ENSG00000101307 Signal-regulatory protein beta 1 20 1563521-1620061 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047463 Uncertain Mixed appendix: 28.8 SLAMF1 CD150, SLAM ENSG00000117090 Signaling lymphocytic activation molecule family member 1 1 160608100-160647295 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002438 Uncertain Tissue enhanced 0 lymph node: 13.1;tonsil: 11.3 appendix: 8.7 SLAMF6 CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000 ENSG00000162739 SLAM family member 6 1 160485030-160523262 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051363, HPA051903 Uncertain Tissue enhanced 0 lymph node: 53.9;tonsil: 41.2 spleen: 26.9 SLAMF7 19A, CD319, CRACC, CS1 ENSG00000026751 SLAM family member 7 1 160739057-160754821 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015445, HPA055945 Supportive Mixed tonsil: 53.1 SLC3A2 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE ENSG00000168003 Solute carrier family 3 (amino acid transporter heavy chain), member 2 11 62856102-62888875 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010455, HPA017980 Supportive Supportive Nucleus, Plasma membrane, Cytoplasm Expressed in all kidney: 130.1 SLC44A1 CD92, CDW92, CHTL1, CTL1 ENSG00000070214 Solute carrier family 44 (choline transporter), member 1 9 105244622-105439171 CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064714 Supportive Mitochondria, Nucleus but not nucleoli Expressed in all cerebral cortex: 56.0 SLC4A1 AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR ENSG00000004939 Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17 44248385-44268141 Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015584, CAB034438, HPA063911 Supportive Tissue enriched 8 bone marrow: 206.1 kidney: 26.0 SPN CD43, GPL115, LSN ENSG00000197471 Sialophorin 16 29662979-29670876 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002666, HPA055244 Supportive Uncertain Plasma membrane, Golgi apparatus, Cell Junctions Tissue enhanced 0 bone marrow: 31.7 lymph node: 17.6 TEK CD202b, TIE-2, TIE2, VMCM, VMCM1 ENSG00000120156 TEK tyrosine kinase, endothelial 9 27109141-27230175 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010359, HPA011738 Uncertain Mixed lung: 28.6 TFRC CD71, p90, TFR1 ENSG00000072274 Transferrin receptor 3 196027183-196082189 Cancer-related genes, CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000153, HPA028598 Uncertain Supportive Vesicles Expressed in all bone marrow: 130.5 THBD CD141 ENSG00000178726 Thrombomodulin 20 23045633-23049741 Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002425, HPA002982 Supportive Expressed in all lung: 48.3 THY1 CD90 ENSG00000154096 Thy-1 cell surface antigen 11 119417378-119424985 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003733, CAB068243, CAB068244 Supportive Tissue enhanced 0 smooth muscle: 259.9 cerebral cortex: 204.5 TLR3 CD283 ENSG00000164342 Toll-like receptor 3 4 186069152-186088069 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025658 Uncertain Mixed placenta: 14.2 TLR4 ARMD10, CD284, hToll, TLR-4 ENSG00000136869 Toll-like receptor 4 9 117704332-117716871 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004025, HPA049174 Uncertain Uncertain Nucleus but not nucleoli Expressed in all spleen: 26.7 TLR8 CD288 ENSG00000101916 Toll-like receptor 8 X 12906620-12923169 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001608 Supportive Tissue enhanced 0 appendix: 15.4 spleen: 8.8 TLR9 CD289 ENSG00000239732 Toll-like receptor 9 3 52221080-52226163 CD markers, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004731 Uncertain Tissue enhanced 0 lymph node: 2.4 spleen: 1.5 TNFRSF10A Apo2, CD261, DR4, TRAILR-1 ENSG00000104689 Tumor necrosis factor receptor superfamily, member 10a 8 23190452-23225126 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054475 Uncertain Uncertain Nucleus, Cytoplasm Mixed tonsil: 11.1 TNFRSF10B CD262, DR5, KILLER, TRAIL-R2, TRICK2A, TRICKB ENSG00000120889 Tumor necrosis factor receptor superfamily, member 10b 8 23020133-23069179 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023625 Uncertain Expressed in all gallbladder: 19.4 TNFRSF10C CD263, DcR1, LIT, TRAILR3, TRID ENSG00000173535 Tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain 8 23084355-23117437 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025635 Uncertain Tissue enhanced 0 appendix: 12.8 spleen: 9.8 TNFRSF11A CD265, FEO, LOH18CR1, PDB2, RANK ENSG00000141655 Tumor necrosis factor receptor superfamily, member 11a, NFKB activator 18 62325287-62391292 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010391, HPA027728 Supportive Tissue enhanced 0 duodenum: 22.6 colon: 14.9 TNFRSF12A CD266, FN14, TweakR ENSG00000006327 Tumor necrosis factor receptor superfamily, member 12A 16 3018445-3022383 Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007853, CAB015941 Uncertain Uncertain Plasma membrane, Cytoplasm, Cytoskeleton (Microtubules) Expressed in all gallbladder: 53.7 TNFRSF13B CD267, TACI ENSG00000240505 Tumor necrosis factor receptor superfamily, member 13B 17 16929816-16972118 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030453 Uncertain Tissue enhanced 0 lymph node: 14.5;spleen: 20.9;tonsil: 18.6 appendix: 8.0 TNFRSF13C BAFFR, CD268 ENSG00000159958 Tumor necrosis factor receptor superfamily, member 13C 22 41925041-41926818 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003246, CAB008380 Supportive Uncertain Nucleus Group enriched 8 appendix: 13.6;lymph node: 25.8;spleen: 27.1;tonsil: 24.0 bone marrow: 2.8 TNFRSF14 ATAR, CD270, HVEA, HVEM, LIGHTR, TR2 ENSG00000157873 Tumor necrosis factor receptor superfamily, member 14 1 2555639-2565382 Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006404, CAB026150, CAB030007 Uncertain Uncertain Cytoplasm Expressed in all lymph node: 47.2 TNFRSF18 AITR, CD357, GITR ENSG00000186891 Tumor necrosis factor receptor superfamily, member 18 1 1203508-1206691 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA008025 Uncertain Tissue enhanced 0 skin: 19.3 appendix: 3.8 TNFRSF1A CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60 ENSG00000067182 Tumor necrosis factor receptor superfamily, member 1A 12 6328757-6342114 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004102, CAB010309 Uncertain Uncertain Mitochondria Expressed in all gallbladder: 93.6 TNFRSF1B CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80 ENSG00000028137 Tumor necrosis factor receptor superfamily, member 1B 1 12167003-12209228 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004796, CAB013045 Uncertain Expressed in all appendix: 55.6 TNFRSF21 CD358, DR6 ENSG00000146072 Tumor necrosis factor receptor superfamily, member 21 6 47231532-47309905 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006746, CAB009805 Uncertain Uncertain Cytoplasm, Nucleoli Expressed in all urinary bladder: 81.2 TNFRSF4 ACT35, CD134, OX40, TXGP1L ENSG00000186827 Tumor necrosis factor receptor superfamily, member 4 1 1211326-1214138 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB016128 Supportive Tissue enhanced 0 adipose tissue: 5.8 lymph node: 4.2 TNFRSF8 CD30, D1S166E, KI-1 ENSG00000120949 Tumor necrosis factor receptor superfamily, member 8 1 12063377-12144207 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000016, HPA032081, HPA032082 Supportive Mixed appendix: 2.0 TNFSF10 Apo-2L, CD253, TL2, TRAIL ENSG00000121858 Tumor necrosis factor (ligand) superfamily, member 10 3 172505508-172523507 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054938 Uncertain Uncertain Cytoskeleton (Microtubules) Expressed in all lung: 165.7 TNFSF11 CD254, ODF, OPGL, RANKL, TRANCE ENSG00000120659 Tumor necrosis factor (ligand) superfamily, member 11 13 42562736-42608013 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009193, HPA045142 Supportive Tissue enhanced 0 lymph node: 13.2 appendix: 4.6 TNFSF13 APRIL, CD256 ENSG00000161955 Tumor necrosis factor (ligand) superfamily, member 13 17 7558292-7561608 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA004863 Uncertain Expressed in all lung: 73.1 TNFSF13B BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20 ENSG00000102524 Tumor necrosis factor (ligand) superfamily, member 13b 13 108251240-108308484 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009188 Uncertain Mixed appendix: 25.7 TNFSF14 CD258, HVEM-L, LIGHT, LTg ENSG00000125735 Tumor necrosis factor (ligand) superfamily, member 14 19 6661253-6670588 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012700 Uncertain Mixed liver: 4.4 TNFSF4 CD252, gp34, OX-40L, TXGP1 ENSG00000117586 Tumor necrosis factor (ligand) superfamily, member 4 1 173183734-173207313 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA059579 Uncertain Uncertain Nucleus, Vesicles Mixed testis: 4.0 TREM1 CD354, TREM-1 ENSG00000124731 Triggering receptor expressed on myeloid cells 1 6 41267926-41286719 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA005563 Uncertain Tissue enhanced 0 appendix: 38.6;bone marrow: 44.2;lung: 47.6 adipose tissue: 13.7 TSPAN7 A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 ENSG00000156298 Tetraspanin 7 X 38561370-38688920 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003140, CAB062566, CAB068245 Supportive Tissue enhanced 0 cerebral cortex: 317.8 adrenal gland: 65.8 VCAM1 CD106 ENSG00000162692 Vascular cell adhesion molecule 1 1 100719742-100739045 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005426, HPA034796 Supportive Tissue enhanced 0 spleen: 305.1 lymph node: 84.7 VPREB1 CD179A, VpreB ENSG00000169575 Pre-B lymphocyte 1 22 22244675-22245515 CD markers, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055886 Uncertain Tissue enriched 13 bone marrow: 12.0 tonsil: 0.9